Concepedia

Xiaoxue Lai

XL

Statistics

Publications

8

Citations

234

H-Index

8

Active since

2020

Affiliations

Shenyang Pharmaceutical University(Current)

Xiaoxue Lai is an author at Shenyang Pharmaceutical University specializing in immunology, nanomedicine, and drug delivery.

Publications per year

2020–2023

8

Publications

8

Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy

Cong Li, Qiujun Qiu, Xin Gao et al. · Journal of Controlled Release · 2021 · 56 citations

, , +14

Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages – A promising cancer immunotherapy

Xueying Tang, Dezhi Sui, Mingqi Liu et al. · International Journal of Pharmaceutics · 2020 · 39 citations

, , +15

Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation

Shuo Wang, Xiaoxue Lai, Cong Li et al. · Journal of Controlled Release · 2021 · 39 citations

, , +14

Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases

Shuo Wang, Yuequan Wang, Xiaoxue Lai et al. · ACS Nano · 2023 · 39 citations

, , +16

Sialic Acid Conjugate–Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size

Shuo Wang, Shuaishuai Yang, Xiaoxue Lai et al. · AAPS PharmSciTech · 2021 · 19 citations

, , +14

1–5 of 8